{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:58:15Z","timestamp":1770134295517,"version":"3.49.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1093\/ndt\/gfp371","type":"journal-article","created":{"date-parts":[[2009,8,9]],"date-time":"2009-08-09T00:24:49Z","timestamp":1249777489000},"page":"3640-3651","source":"Crossref","is-referenced-by-count":17,"title":["Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies\u2014the effect on podocytes"],"prefix":"10.1093","volume":"24","author":[{"given":"Zalan","family":"Nemeth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor","family":"Kokeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Godo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikl\u00f3s","family":"M\u00f3zes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Rosivall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Luise","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Hamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,8,8]]},"reference":[{"key":"key\n\t\t\t\t20170515175810_R1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0272-6386(89)80001-0","article-title":"Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis","volume":"13","author":"Rennke","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170515175810_R2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1681\/ASN.V1261315","article-title":"Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation","volume":"12","author":"Hostetter","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175810_R3","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1159\/000066656","article-title":"The renin\u2013angiotensin system and progression of renal disease: from hemodynamics to cell biology","volume":"93","author":"Wolf","year":"2003","journal-title":"Nephron Physiol"},{"key":"key\n\t\t\t\t20170515175810_R4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1523-1755.2005.00145.x","article-title":"Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications","volume":"67","author":"Wolf","year":"2005","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175810_R5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI114846","article-title":"Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat","volume":"86","author":"Seikaly","year":"1990","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170515175810_R6","first-page":"2","article-title":"The intrarenal renin\u2013angiotensin system: a paracrine system for the local control of renal function separate from the systemic axis","volume":"4","author":"Harris","year":"1996","journal-title":"Exp Nephrol"},{"key":"key\n\t\t\t\t20170515175810_R7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/hy0102.100536","article-title":"Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats","volume":"39","author":"Nishiyama","year":"2002","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515175810_R8","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1097\/01.ASN.0000071512.93927.4E","article-title":"Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease","volume":"14","author":"Huang","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175810_R9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.HYP.31.2.692","article-title":"Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats","volume":"31","author":"Richer","year":"1998","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515175810_R10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s11906-003-0087-9","article-title":"RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal disease","volume":"5","author":"Lakkis","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"key\n\t\t\t\t20170515175810_R11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(01)80115-3","article-title":"Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications","volume":"37","author":"Epstein","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170515175810_R12","doi-asserted-by":"crossref","first-page":"F1059","DOI":"10.1152\/ajprenal.00202.2003","article-title":"Effect of aldosterone on renal transforming growth factor-beta","volume":"286","author":"Juknevicius","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20170515175810_R13","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","article-title":"Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo","volume":"58","author":"Brown","year":"2000","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175810_R14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/diab.43.1.95","article-title":"Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen","volume":"43","author":"Wakisaka","year":"1994","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20170515175810_R15","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170515175810_R16","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1097\/01.ASN.0000034912.55186.EC","article-title":"How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach","volume":"13","author":"Zoja","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175810_R17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM200109203451215","article-title":"Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease","volume":"345","author":"Chrysostomou","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515175810_R18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1291\/hypres.31.59","article-title":"Effect of renin\u2013angiotensin\u2013aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker","volume":"31","author":"Furumatsu","year":"2008","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t20170515175810_R19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1291\/hypres.27.971","article-title":"Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis","volume":"27","author":"Asai","year":"2004","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t20170515175810_R20","first-page":"F-PO437","article-title":"Protective effect of combining ACE inhibition and aldosterone receptor blockade on renal structural damage in experimental nephrosis","volume":"16","author":"Van Der Meulen","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175810_R21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ndt\/gfn448","article-title":"Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats","volume":"24","author":"Kang","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515175810_R22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00004872-199309000-00011","article-title":"The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis","volume":"11","author":"Amann","year":"1993","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170515175810_R23","first-page":"957","article-title":"Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats","volume":"78","author":"Pfeffer","year":"1971","journal-title":"J Lab Clin Med"},{"key":"key\n\t\t\t\t20170515175810_R24","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/clinchem\/35.7.1371","article-title":"Microplate measurement of urinary albumin and creatinine","volume":"35","author":"Magnotti","year":"1989","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170515175810_R25","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1097\/01.ASN.0000095248.91994.D3","article-title":"Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats","volume":"14","author":"Adamczak","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175810_R26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ki.1987.189","article-title":"Chronic renal failure after nephrotoxic nephritis in rats: contributions to progression","volume":"32","author":"el Nahas","year":"1987","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175810_R27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ki.1994.290","article-title":"Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats","volume":"46","author":"V\u00e9niant","year":"1994","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175810_R28","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1046\/j.1523-1755.1998.00951.x","article-title":"Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats","volume":"53","author":"Schwarz","year":"1998","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175810_R29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/ndt\/11.6.1003","article-title":"Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure","volume":"11","author":"Amann","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515175810_R30","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/ndt\/gfg578","article-title":"No aggravation of renal injury in apolipoprotein E knockout mice (ApoE(\u2212\/\u2212)) after subtotal nephrectomy","volume":"19","author":"Buzello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515175810_R31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00125-003-1106-8","article-title":"ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy","volume":"46","author":"Gross","year":"2003","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t20170515175810_R32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(85)90078-6","article-title":"Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model","volume":"79","author":"Raij","year":"1985","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170515175810_R33","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat","volume":"77","author":"Anderson","year":"1986","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170515175810_R34","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1681\/ASN.2005111196","article-title":"Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats","volume":"17","author":"Han","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175810_R35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.ki.5000438","article-title":"Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats","volume":"70","author":"Han","year":"2006","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175810_R36","doi-asserted-by":"crossref","first-page":"F137","DOI":"10.1152\/ajprenal.00065.2008","article-title":"Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination","volume":"295","author":"Piecha","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20170515175810_R37","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.HYP.0000127924.67353.86","article-title":"Determinants of blood pressure response to quinapril in black and white hypertensive patients: the quinapril Titration Interval Management Evaluation trial","volume":"43","author":"Mokwe","year":"2004","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170515175810_R38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/clc.20324","article-title":"A comparison of the aldosterone-blocking agents eplerenone and spironolactone","volume":"31","author":"Struthers","year":"2008","journal-title":"Clin Cardiol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/24\/12\/3640\/17107484\/gfp371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T13:38:02Z","timestamp":1633786682000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfp371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,8]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2009,8,8]]},"published-print":{"date-parts":[[2009,12]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfp371","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8,8]]}}}